🇺🇸 FDA
Company

Cellectar

Cellectar Biosciences

CLRB pharma USA

Quick answer

Cellectar is a pharma company (CLRB) headquartered in FLORHAM PARK, NJ, USA with 15 tracked pipeline programs.

Pipeline (15)

project

Paclitaxel

Non Small Cell Lung Cancer

Phase 3 · small_molecule · completed

1 trials project

I-124-CLR1404

Glioblastoma

Phase 2 · small_molecule · terminated

1 trials project

I-131-CLR1404 Injection

Glioma

Phase 2 · small_molecule · terminated

1 trials project

Iopofosine I 131 single dose

Waldenstrom Macroglobulinemia

Phase 2 · small_molecule · active

1 trials project

NOV-002

Ovarian Cancer

Phase 2 · small_molecule · completed

1 trials project

NOV-002

Leukemia

Phase 2 · small_molecule · terminated

1 trials project

NOV-205

Hepatitis C

Phase 2 · small_molecule · completed

2 trials project

CLR 131

Head and Neck Cancer

Phase 1 · small_molecule · completed

1 trials project

CLR 131

High-Grade Glioma

Phase 1 · small_molecule · active

1 trials project

CLR 131

Pediatric Solid Tumor

Phase 1 · small_molecule · active

1 trials project

I-131-CLR1404

Solid Tumors

Phase 1 · small_molecule · completed

1 trials project

I-131-CLR1404

Multiple Myeloma

Phase 1 · small_molecule · completed

1 trials project

I-131-CLR1404

Cancer

Phase 1 · small_molecule · completed

1 trials project

I124-NM404

Non Small Cell Lung Cancer

Phase 1 · small_molecule · completed

1 trials project

Iopofosine I 131

Breast Cancer

Phase 1 · small_molecule · active

1 trials

Patents (7)

patent

US 11439709

Phospholipid ether analogs as cancer-targeting drug vehicles

Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9925269

Phospholipid ether analogs as cancer-targeting drug vehicles

Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9616140

Fluorescent phospholipid ether compounds, compositions, and methods of use

Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9579406

Phospholipid ether analogs as agents for detecting and locating cancer, and meth

Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9550002

Phospholipid analogs as diapeutic agents and methods thereof

Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9480754

Phospholipid ether analogs as cancer-targeting drug vehicles

Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9345718

Phospholipid ether analogs as cancer-targeting drug vehicles

Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)